Meta-analysis of 31 studies (15 005 dermatologic patients on systemic therapy): pooled latent TB conversion incidence was 4.3%, highest with TNF inhibitors, then IL-17 inhibitors and ustekinumab; active TB incidence was 1.0%, more frequent in high-burden regions.
Meta-analysisn = 15,005
Liu et al. Tuberculosis-Related Outcomes in Dermatologic Patients Receiving Systemic Therapy: A Systematic Review and Meta-Analysis